Conyers Dill & Pearman Pte. Ltd. provided Bermuda legal advice to The Carlyle Group (NASDAQ: CG) L.P. in relation to an acquisition of Ortho-Clinical Diagnostics, Inc. (”OCD”) for approximately US$4 billion. OCD, formerly a subsidiary of Johnson & Johnson, is a global provider of solutions for screening, diagnosing, monitoring and confirming diseases.
The Carlyle Group is a global alternative asset manager with US$199 billion of assets under management across 120 funds and 133 fund of funds vehicles as of 31 March 2014. The Carlyle Group is based in Washington, D.C. and has offices around the world.
Christopher Page and Sherwin Lin of Conyers’ Singapore office advised on the matter alongside Latham & Watkins LLP.